Raízen S.A. (RAIZ4)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 0.370 |
|---|---|
| 52-week range | 0.210 – 1.130 |
| Return, 1 month / 3 months | +32.1% / +27.6% |
| Return, 1 year / 3 years | −57.5% / −88.8% |
| Trend | Below its 200-day average |
| RSI (14) | 65 |
| Volatility (1 year) | 74.2% |
| Worst drawdown (1 year) | -79.6% |
| Average daily value traded | 4.71M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Raízen is a Brazilian energy company formed as a joint venture between Shell and Cosan. It produces sugar and ethanol from sugarcane and generates electricity from biomass at its mills. The company distributes fuels and operates Shell-branded service stations across Brazil, serving motorists and commercial customers, and it also runs convenience stores at its stations. Its operations span the sugar, ethanol, fuel distribution and renewable energy businesses, with its headquarters in Brazil.
Raízen S.A. trades under the code RAIZ4 on the Sao Paulo Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Raízen S.A. (RAIZ4) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 0.370 on 16 October 2026.
Its price-based Market X-Ray is 27 out of 100 (a weak price profile), ranking 1,259 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 57.5% and over the last three months it rose 27.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 6 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -22.0% | ||
| From 52-week high | -65.7% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 27.6% | ||
| 6-month return | -30.2% | ||
| 12-month return, skipping the last month | -67.8% | ||
| Stability (higher is calmer) | 9 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 74.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -79.6% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 4.71M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +8.8% |
|---|---|
| 1 month | +32.1% |
| 3 months | +27.6% |
| 6 months | −30.2% |
| 1 year | −57.5% |
| 3 years | −88.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 0.280 / 0.474 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.026 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Aug 2024 | BRL 0.0100 |
| 21 Mar 2024 | BRL 0.0162 |
| 20 Dec 2023 | BRL 0.1290 |
| 17 Oct 2023 | BRL 0.0242 |
| 26 Jul 2023 | BRL 0.0242 |
| 16 Mar 2023 | BRL 0.0891 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.